Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Karyopharm Announces Submission of Marketing Authorization Application to the European Medicines Agency for Selinexor for the Treatment of Patients with Penta-Refractory Multiple Myeloma

firstwordpharmaJanuary 09, 2019

Tag: European Medicines Agency , submission , Karyopharm , European Medicines Agency

PharmaSources Customer Service